Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population

被引:131
作者
Lee, SC
Ng, SS
Oldenburg, J
Chong, PY
Rost, S
Guo, JY
Yap, HL
Rankin, SC
Khor, HB
Yeo, TC
Ng, KS
Soong, R
Goh, BC
机构
[1] Natl Univ Singapore, Oncol Res Inst, Natl Univ Hosp, Dept Haematol Oncol, Singapore 119074, Singapore
[2] Natl Univ Singapore, Oncol Res Inst, Natl Univ Hosp, Dept Cardiol, Singapore 119074, Singapore
[3] Tan Tock Seng Hosp, Dept Cardiol, Singapore, Singapore
[4] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[5] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany
关键词
D O I
10.1016/j.clpt.2005.11.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background. Chinese and Malay subjects have been reported to require less maintenance warfarin than Indians that could not be accounted for by cytochrome P450 (CYP) 2C9 variants. Vitamin K epoxide reductase complex 1 (VKORC1) is the target enzyme of warfarin, and VKORC1 intronic variants and haplotypes have recently been shown to influence VKORC1 activity and warfarin requirements. Methods: We sequenced the coding regions of CYP2C9 and VKORC1 and inferred VKORC1 haplotype from 10 intronic variants in 147 Chinese, 85 Malay, and 43 Indian patients receiving maintenance warfarin. Results: The mean weight-normalized warfarin dose was lower for Chinese and Malays than for Indians (0.058 +/- 0.025 mg/kg, 0.059 +/- 0.023 mg/kg, and 0.089 +/- 0.036 mg/kg, respectively; P < .001 for comparisons between Chinese and Malays with Indians). CYP2C9*2 and VKORC1 coding region variants were rare (<2%), whereas CYP2C9*3 associated with lower warfarin requirements was less common in Chinese and Malays (7% and 9%, respectively) than in Indians (18%) and could not account for their lower warfarin requirements. VKORC1 HI and H7/H8/H9 haplotypes were associated with lower and higher warfarin requirements, respectively (0.050 +/- 0.019 mg/kg and 0.092 +/- 0.057 mg/kg, respectively; P < .001). VKORC1 H1 haplotype (requiring low warfarin doses) was common in Chinese (87%) and Malays (65%) but uncommon in Indians (12%), whereas H7, H8, and H9 haplotypes (requiring high warfarin doses) were rare in Chinese (9%), intermediate in Malays (30%), and common in Indians (82%). The interethnic difference in warfarin requirements became nonsignificant when adjusted for VKORC1 haplotype. Conclusions. Interethnic difference in VKORC1 haplotypes accounts for the difference in warfarin requirements between Chinese, Malays, and Indians, providing interesting insights into genetic variation between ethnogeographically distinct Asian groups.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 34 条
[1]   An apportionment of human DNA diversity [J].
Barbujani, G ;
Magagni, A ;
Minch, E ;
CavalliSforza, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4516-4519
[2]   Racial background is a determinant of average warfarin dose required to maintain the INR between 2•0 and 3•0 [J].
Blann, A ;
Hewitt, J ;
Siddiqui, F ;
Bareford, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) :207-209
[3]   Cytochrome P4502C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity [J].
Bodin, L ;
Verstuyft, C ;
Tregouet, DA ;
Robert, A ;
Dubert, L ;
Funck-Brentano, C ;
Jaillon, P ;
Beaune, P ;
Laurent-Puig, P ;
Becquemont, L ;
Loriot, MA .
BLOOD, 2005, 106 (01) :135-140
[4]   Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane [J].
Cain, D ;
Hutson, SM ;
Wallin, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :29068-29075
[5]   A COMPARISON OF VERAPAMIL AND PROPRANOLOL FOR THE INITIAL TREATMENT OF HYPERTENSION - RACIAL-DIFFERENCES IN RESPONSE [J].
CUBEDDU, LX ;
ARANDA, J ;
SINGH, B ;
KLEIN, M ;
BRACHFELD, J ;
FREIS, E ;
ROMAN, J ;
EADES, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (16) :2214-2221
[6]   A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin [J].
D'Andrea, G ;
D'Ambrosio, RL ;
Di Perna, P ;
Chetta, M ;
Santacroce, R ;
Brancaccio, V ;
Grandone, E ;
Margaglione, M .
BLOOD, 2005, 105 (02) :645-649
[7]   Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians [J].
DeLozier, TC ;
Lee, SC ;
Coulter, SJ ;
Goh, BC ;
Goldstein, JA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1085-1090
[8]   Racial background is a determinant factor in the maintenance dosage of warfarin [J].
Gan, GG ;
Teh, A ;
Goh, KY ;
Chong, HT ;
Pang, KW .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (01) :84-86
[9]   Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies [J].
Goh, BC ;
Lee, SC ;
Wang, LZ ;
Fan, L ;
Guo, JY ;
Lamba, J ;
Schuetz, E ;
Lim, R ;
Lim, HL ;
Ong, AB ;
Lee, HS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3683-3690
[10]   Vitamin K epoxide reductase: homology, active site and catalytic mechanism [J].
Goodstadt, L ;
Ponting, CP .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (06) :289-292